XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.2
General (Tables)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Schedule of Error Corrections and Prior Period Adjustments The impact of the revision on the Company’s financial statements for the three and six months ended June 30, 2022 is reflected in the following table:
(In thousands)As previously reported
Adjustment
As revised
Balance Sheet for June 30, 2022 (unaudited)
Additional paid-in capital$435,922 $1,299 $437,221 
Accumulated deficit$(438,836)$(1,299)$(440,135)
Consolidated Statement of Operations and Comprehensive Loss for the three months ended June 30, 2022 (unaudited)
Research and development expenses$5,456 $150 $5,606 
Selling, general and administrative expenses4,145 352 4,497 
Total operating expenses9,601 502 10,103 
Operating loss(8,984)(502)(9,486)
Net loss(9,657)(502)(10,159)
Total other comprehensive loss(9,688)(502)(10,190)
Basic and diluted loss per common share$(1.18)$(0.06)$(1.24)
Consolidated Statement of Operations and Comprehensive Loss for the six months June 30, 2022 (unaudited)
Research and development expenses$9,696 $391 $10,087 
Selling, general and administrative expenses7,791 908 8,699 
Total operating expenses17,487 1,299 18,786 
Operating loss(16,527)(1,299)(17,826)
Net loss(17,860)(1,299)(19,159)
Total other comprehensive loss(17,889)(1,299)(19,188)
Basic and diluted loss per common share$(2.18)$(0.16)$(2.34)
Consolidated statement of Stockholders’ Equity (Deficit) for the three months ended June 30, 2022 (unaudited)
Compensation expense for issuance of stock options$1,617 $502 $2,119 
Net loss$(9,657)$(502)$(10,159)
Consolidated statement of Stockholders’ Equity (Deficit) for the six months ended June 30, 2022 (unaudited)
Compensation expense for issuance of stock options$3,091 $1,299 $4,390 
Net loss$(17,860)$(1,299)$(19,159)
Consolidated Statement of Cash Flows for the six months ended June 30, 2022 (unaudited)
Net loss$(17,860)$(1,299)$(19,159)
Stock option compensation expense$3,091 $1,299 $4,390